BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20006385)

  • 1. Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1.
    Koti M; Farrugia W; Nagy E; Ramsland PA; Kaushik AK
    Mol Immunol; 2010 Feb; 47(5):953-60. PubMed ID: 20006385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single point mutation in framework region 3 of heavy chain affects viral neutralization dynamics of single-chain Fv against bovine herpes virus type 1.
    Koti M; Nagy E; Kaushik AK
    Vaccine; 2011 Oct; 29(45):7905-12. PubMed ID: 21872632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exceptionally long CDR3H of bovine scFv antigenized with BoHV-1 B-epitope generates specific immune response against the targeted epitope.
    Pasman Y; Soliman C; Ramsland PA; Kaushik AK
    Mol Immunol; 2016 Sep; 77():113-25. PubMed ID: 27497190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VH and VL Domains of Polyspecific IgM and Monospecific IgG Antibodies Contribute Differentially to Antigen Recognition and Virus Neutralization Functions.
    Pasman Y; Kaushik AK
    Scand J Immunol; 2016 Jul; 84(1):28-38. PubMed ID: 27104652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an epitope within the Bovine herpesvirus 1 glycoprotein E cytoplasmic tail and use of a monoclonal antibody directed against the epitope for the differentiation between vaccinated and infected animals.
    Chowdhury SI
    J Virol Methods; 2016 Jul; 233():97-104. PubMed ID: 26976821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody-based ELISA allows discrimination between responses induced by bovine herpesvirus subtypes 1 (BoHV-1.1) and 2 (BoHV-1.2).
    Spilki FR; Esteves PA; da Silva AD; Franco AC; Rijsewijk FA; Roehe PM
    J Virol Methods; 2005 Nov; 129(2):191-3. PubMed ID: 16046004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced bovine herpesvirus type 1 neutralization by multimerized single-chain variable antibody fragments regardless of differential glycosylation.
    Pasman Y; Nagy E; Kaushik AK
    Clin Vaccine Immunol; 2012 Aug; 19(8):1150-7. PubMed ID: 22695166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis.
    Muylkens B; Thiry J; Kirten P; Schynts F; Thiry E
    Vet Res; 2007; 38(2):181-209. PubMed ID: 17257569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping a highly conserved linear neutralizing epitope at the N-terminus of the gD glycoprotein of bovine herpesvirus type I using a monoclonal antibody.
    Ni H; Jia XX; Wang J; Ran X; Wen X
    Microb Pathog; 2020 Jan; 138():103815. PubMed ID: 31654778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine single chain Fv antibody inhibits bovine herpesvirus-1 infectivity by targeting viral glycoprotein D.
    Xu J; Wu J; Jiang B; He H; Zhang X; Li X; Yang D; Huang X; Sealy JE; Iqbal M; Li Y
    Appl Microbiol Biotechnol; 2017 Dec; 101(23-24):8331-8344. PubMed ID: 29063173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus, strain, and epitope specificities of neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD, with sequence and molecular model analysis.
    Levings RL; Collins JK; Patterson PA; Roth JA
    Vet Immunol Immunopathol; 2015 Apr; 164(3-4):179-93. PubMed ID: 25771882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
    Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
    Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel atypical nucleotide insertions specifically at VH-DH junction generate exceptionally long CDR3H in cattle antibodies.
    Koti M; Kataeva G; Kaushik AK
    Mol Immunol; 2010 Jul; 47(11-12):2119-28. PubMed ID: 20435350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
    Chin LT; Chu C; Chen HM; Hsu SC; Weng BC; Chu CH
    BMC Biotechnol; 2007 Aug; 7():51. PubMed ID: 17714596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization.
    Yuan W; Parrish CR
    Virology; 2000 Apr; 269(2):471-80. PubMed ID: 10753725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency.
    Duan Y; Gu TJ; Jiang CL; Yuan RS; Zhang HF; Hou HJ; Yu XH; Chen Y; Zhang Y; Wu YG; Kong W
    Mol Immunol; 2012 Jun; 51(2):188-96. PubMed ID: 22484084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of bovine herpesvirus type 1 strains with monoclonal antibodies.
    Egyed L; Brocchi E; Rusvai M; Bartha A
    Acta Vet Hung; 1992; 40(3):225-30. PubMed ID: 1284321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.